Lawood & Co’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Lawood & Co's BMY Position: Q2 2026 in Review
Lawood & Co reduced its Bristol-Myers Squibb (BMY) stake by 5.8% in Q2 2026, selling an estimated $26.6K and leaving 7,561 shares worth $436K. The position accounts for 0.3% of the portfolio, ranked #63.
Lawood & Co first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $487K in Q1 2026. 2,513 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Lawood & Co held 7,561 shares of Bristol-Myers Squibb worth $436K as of Q2 2026.
- Lawood & Co sold 464 Bristol-Myers Squibb shares in Q2 2026, an estimated $26.6K.
- Bristol-Myers Squibb made up 0.3% of Lawood & Co's portfolio in Q2 2026, its #63 holding.
- Lawood & Co first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Lawood & Co's Bristol-Myers Squibb position peaked at $487K in Q1 2026.
- 2,513 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Lawood & Co's 13F filing for Q2 2026, filed 13 Jul 2026.